Research

Energy balance

Weight loss of 10-15% in patients with obesity and Type 2 Diabetes has disease-modifying effects, including improved glycaemic control, reduced need for medication, and potential disease remission.

For patients with obesity and Type 2 Diabetes, aim for a weight loss of 10-15% of body weight. This level of loss is not just for appearance but can modify the disease course, potentially leading to remission and reduced medication needs. This is particularly important for those with higher BMI.

ModerateSupportsMEDIUM confidence
reductions of higher magnitude (10%–15%) have shown disease- modifying effects, meaning an improved glycaemic control in the presence of a reduced need for diabetes medications or even disease remission [2, 7–9].
Concha F. García‐Prieto et al. · Endocrinology Diabetes & Metabolism · 2025

Why this rating

Based on cited guidelines and observational studies referenced in the paper.

Source

Insights Into the Management of Type 2 Diabetes at Diagnosis in Spain: The <scp>NEW2TYPE2</scp> Study

Concha F. García‐Prieto et al. · Endocrinology Diabetes & Metabolism · 2025

DOI 10.1002/edm2.70095

cross_sectional · n=105
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →